2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 1036

Synergism Between GM-CSF and IL-17 Causes Enhanced Joint Pathology Via the Production of IL-6 and IL-23
Abstract Number: 1472

Synovial Fluid from Rheumatoid Arthritis Patients Modulates the Immunophenotype and Viability of Monocytes
Abstract Number: 2950

Synovial Macrophages Promote TGF-β Activation after Intra-Articular Injections of Oxidized LDL in Naïve Murine Knee Joints, Preventing Production of Pro-Inflammatory Factors S100A8/9, Chemokines and Aggrecanase-Induced Neo-Epitopes
Abstract Number: 1292

Synovitis Characteristics and Associated Intra-Articular Pathology in a Cohort of Patients Undergoing Meniscectomy for Meniscal Tear
Abstract Number: 1100

System Review: The Most Common Symptoms of Fibromyalgia Patients Other Than Pain, Fatigue, Insomnia, and Cognitive Dysfunction
Abstract Number: 2044

Systematic Review of the Effect of Anti-Rheumatic Therapies upon Vaccine Immunogenicity
Abstract Number: 2906

Systemic Delivery of Short Hairpin RNA Targeting Calcium Release-Activated Calcium Channel 3 Down-Regulates Severity of Collagen-Induced Arthritis
Abstract Number: 1429

Systemic Inflammation in Alzheimer’s Disease: Relevance to Patients with Rheumatoid Arthritis
Abstract Number: 2779

Systemic Inflammatory and Autoimmune Manifestations Associated with Myelodysplastic Syndrome: A French Multicenter Retrospective Study
Abstract Number: 319

Systemic Juvenile Idiopathic Arthritis and Exposure to Fine Particulate Air Pollution
Abstract Number: 2669

Systemic Lupus Erythematosus and Lactation: Factors Affecting Infant Feeding Choices in Women with SLE
Abstract Number: 2622

Systemic LUPUS Erythematosus in Spanish Males
Abstract Number: 1854

Systemic Lupus Erythematosus Patients Have Increased Risk of Short Term Adverse Events after Total Hip Arthroplasty
Abstract Number: 1282

Systemic Pain Modulation Is Related to Body Perception in People with Knee Osteoarthritis
Abstract Number: 747

Systemic Sclerosis Patients with Antitopoisomerase Antibodies Showed Significant Association with CCR6 Polymorphisms

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].